Back to BANK OF AMERICA CORP /DE/ BANK OF AMERICA CORP /DE/

RLMDRLMD
7 quarters

Position history for BANK OF AMERICA CORP /DE/BANK OF AMERICA CORP /DE/'s holdings in RELMADA THERAPEUTICS INC

BANK OF AMERICA CORP /DE/ holds 812,059 shares of RLMD (RELMADA THERAPEUTICS INC), worth $5.6M as of 2026-Q2. The position was increased (+544.8% shares). RLMD represents 0.0% of BANK OF AMERICA CORP /DE/'s portfolio.

Current Value

$5.6M

Current Shares

812,059

Total Value Change

+$5.5M

Total Shares Change

+605,402

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
812,059
+544.8%
$5.6M0.0%$6.92
44
2026-Q1
Increased
125,941
+397.0%
$876,5490.0%$4.67
40
2025-Q4
Increased
25,340
+9535.0%
$122,3930.0%$4.53
24
2025-Q3
Decreased
263
-18.8%
$5280.0%$1.88
0
2025-Q2
Decreased
324
-97.6%
$1940.0%$0.61
0
2025-Q1
Decreased
13,716
-93.4%
$3,7030.0%$0.30
0
2024-Q4
New
206,657
-
$107,4620.0%$0.46
33

Other major holders of RLMD: RTW INVESTMENTS, LP, Janus Henderson Group Ltd., RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used